Clinical Trial: Study of the Immunological Pathophysiological Mechanisms Associated With Acute Respiratory Distress Syndrome

U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07395076) titled 'Study of the Immunological Pathophysiological Mechanisms Associated With Acute Respiratory Distress Syndrome' on Jan. 09.

Brief Summary: About 10% of patients admitted to the ICU suffer from ARDS, with a mortality rate of around 35-45%. The lack of therapeutic innovation in ARDS can be partly explained by the heterogeneity of patients included under this definition.

A better understanding of the pathophysiological mechanisms underlying the different patient phenotypes is essential to develop new therapeutic strategies.

Objectives:

To characterize the inflammatory profile of patients with ARDS using circulating biomarkers and sing...